Dr. Sarju Ganatra on SGLT2 Inhibitors and CTRCD

from All Things Cardio-Oncology · host International Cardio-Oncology Society

Dr. Ganatra and Dr. Daniel Lenihan discuss an article they both contributed to titled "SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction" Article Link ⁠https://www.sciencedirect.com/science/article/abs/pii/S2213177923005966⁠ Dr. Sarju Ganatra is Vice Chair of the Department of Medicine at Lahey Hospital Department of Medicine Research Follow him on X: @SarjuGanatraMD

Episode metadata supplied by the publisher feed · Published Jan 12, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Dr. Sarju Ganatra on SGLT2 Inhibitors and CTRCD

0:00 28:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of All Things Cardio-Oncology?

This episode is 28 minutes long.

When was this All Things Cardio-Oncology episode published?

This episode was published on January 12, 2024.

Can I download this All Things Cardio-Oncology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!